1 December 2010Jurisdiction reportsDr. Michael Factor

Oppositions, obviousness and other stories

The product covered by the patent is marketed as Fosomax® and has annual worldwide sales of over $1 billion.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

UK-India trade deal is ‘missed opportunity’, say industry bodies

INTA 2025: San Diego to host largest post-COVID Annual Meeting

Iconix, dupe culture and the risk of post-sale confusion

'Nothing can stand in the way of our work': Ukraine resumes IP system

WATCH: Finding a new balance in IP protection with trade secret protection

Optis v Apple: How the court calculated the royalty rate

Wouter Pors leaves Bird & Bird for boutique Dutch firm

US-China tariffs: What hope is there for IP rightsholders?

Oppositions, obviousness and other stories

Editor's picks

Editor's picks

More articles